The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus apatinib in patients with advanced or recurrent endometrial cancer after failure of at least first-line therapy: Interim results of a single-arm phase II trial.
 
Huaying Wang
No Relationships to Disclose
 
Wenjuan Tian
No Relationships to Disclose
 
Yulan Ren
No Relationships to Disclose
 
Chuyu Jing
No Relationships to Disclose
 
Boer Shan
No Relationships to Disclose